Good research practices for cost-effectiveness analysis alongside clinical trials: the ISPOR RCT-CEA Task Force report.
暂无分享,去创建一个
R. Willke | H. Glick | D. Petitti | A. Briggs | M. Buxton | S. Ramsey | A. Chawla | S. Reed | B. Liljas | Ruth E. Brown | J. Cook
[1] M. Boyle,et al. Multiattribute and Single‐Attribute Utility Functions for the Health Utilities Index Mark 3 System , 2002, Medical care.
[2] Lisa M. Schwartz,et al. Assessing Values for Health: Numeracy Matters , 2001, Medical decision making : an international journal of the Society for Medical Decision Making.
[3] W. Manning,et al. The logged dependent variable, heteroscedasticity, and the retransformation problem. , 1998, Journal of health economics.
[4] S. van der Linden,et al. Responsiveness of the core set, response criteria, and utilities in early rheumatoid arthritis , 2000, Annals of the rheumatic diseases.
[5] Other. World development indicators 2001 , 2001 .
[6] W Sumner,et al. U-titer: a utility assessment tool. , 1991, Proceedings. Symposium on Computer Applications in Medical Care.
[7] J. MacKinnon,et al. Estimation and inference in econometrics , 1994 .
[8] ANALYZING DIFFERENCES IN THE COSTS OF TREATMENT ACROSS CENTERS WITHIN ECONOMIC EVALUATIONS , 2001, International Journal of Technology Assessment in Health Care.
[9] I. White,et al. Choice of test for comparing two groups, with particular application to skewed outcomes , 2003, Statistics in medicine.
[10] A. Kasuya. EuroQol--a new facility for the measurement of health-related quality of life. , 1990, Health policy.
[11] Bernie J. O'Brien,et al. In Search of Power and Significance: Issues in the Design and Analysis of Stochastic Cost-Effectiveness Studies in Health Care , 1994, Medical care.
[12] R. Deyo,et al. The practicality and validity of directly elicited and SF-36 derived health state preferences in patients with low back pain. , 2002, Health economics.
[13] W. Manning,et al. Estimating Log Models: To Transform or Not to Transform? , 1999, Journal of health economics.
[14] Robert L. Mason,et al. Statistical Principles in Experimental Design , 2003 .
[15] M. Smithson. Statistics with confidence , 2000 .
[16] J. Schafer. Multiple imputation: a primer , 1999, Statistical methods in medical research.
[17] F. Salaffi,et al. Responsiveness of Health Status Measures and Utility-based Methods in Patients with Rheumatoid Arthritis , 2002, Clinical Rheumatology.
[18] Morris Meisner,et al. Power and Sample Size in Cost- Effectiveness Analysis , 1999, Medical decision making : an international journal of the Society for Medical Decision Making.
[19] Seymour Geisser,et al. Statistical Principles in Experimental Design , 1963 .
[20] A Briggs,et al. The Distribution of Health Care Costs and Their Statistical Analysis for Economic Evaluation , 1998, Journal of health services research & policy.
[21] P Carlsson,et al. Resource costing for multinational neurologic clinical trials: methods and results. , 1998, Health economics.
[22] R. Willke,et al. Estimating country-specific cost-effectiveness from multinational clinical trials. , 1998, Health economics.
[23] D. Torgerson,et al. Converting international cost effectiveness data to UK prices , 2002, BMJ : British Medical Journal.
[24] A H Briggs,et al. Handling uncertainty when performing economic evaluation of healthcare interventions. , 1999, Health technology assessment.
[25] K. Cook,et al. A Trial for Comparing Methods for Eliciting Treatment Preferences From Men With Advanced Prostate Cancer: Results From the Initial Visit , 2000, Medical care.
[26] Andrew Briggs,et al. The Design and Analysis of Stochastic Cost-Effectiveness Studies for the Evaluation of Health Care Interventions , 2001 .
[27] Richard Willke,et al. Variability of cost-effectiveness estimates for pharmaceuticals in Western Europe: lessons for inferring generalizability. , 2005, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[28] Anthony O'Hagan,et al. Assessing and comparing costs: how robust are the bootstrap and methods based on asymptotic normality? , 2003, Health economics.
[29] S. Wilson. Methods for the economic evaluation of health care programmes , 1987 .
[30] M. Stano,et al. Adjusting to changes in health: implications for cost-effectiveness analysis. , 2004, Journal of health economics.
[31] M. Weinstein,et al. Economic Evaluation Alongside Multinational Clinical Trials: Study Considerations for GUSTO iib , 1997, International Journal of Technology Assessment in Health Care.
[32] A. Gnanasakthy,et al. COMPARISON OF HOSPITAL COSTING METHODS IN AN ECONOMIC EVALUATION OF A MULTINATIONAL CLINICAL TRIAL , 2003, International Journal of Technology Assessment in Health Care.
[33] A. Williams. EuroQol : a new facility for the measurement of health-related quality of life , 1990 .
[34] M. Gold. Cost-effectiveness in health and medicine , 2016 .
[35] R M Kaplan,et al. A general health policy model: update and applications. , 1988, Health services research.
[36] M C Weinstein,et al. Recommendations for reporting cost-effectiveness analyses. Panel on Cost-Effectiveness in Health and Medicine. , 1996, JAMA.
[37] Michael Drummond,et al. Assessing the appropriateness of combining economic data from multinational clinical trials , 2003, Statistics in medicine.
[38] Douglas G. Altman,et al. Statistics Notes: Transforming data , 1996 .
[39] M. Drummond,et al. Issues in the Cross-National Assessment of Health Technology , 1992, International Journal of Technology Assessment in Health Care.
[40] J. Kalbfleisch,et al. The Statistical Analysis of Failure Time Data , 1980 .
[41] M. Kenward,et al. An Introduction to the Bootstrap , 2007 .
[42] T O Jefferson,et al. Guidelines for authors and peer reviewers of economic submissions to the BMJ , 1996, BMJ.
[43] Donald Hedeker,et al. Application of random-efiects pattern-mixture models for miss-ing data in longitudinal studies , 1997 .
[44] R Peto,et al. Large-scale randomized evidence: large, simple trials and overviews of trials. , 1993, Annals of the New York Academy of Sciences.
[45] N. Blomqvist,et al. Estimating confidence intervals for cost-effectiveness ratios: an example from a randomized trial. , 1998, Statistics in medicine.
[46] S. Thompson,et al. Analysis of cost data in randomized trials: an application of the non-parametric bootstrap. , 2000, Statistics in medicine.
[47] D. Patrick,et al. Health Status and Health Policy: Quality of Life in Health Care Evaluation and Resource Allocation , 1993 .
[48] Anthony O'Hagan,et al. On estimators of medical costs with censored data. , 2004, Journal of health economics.
[49] George W. Torrance,et al. Application of Multi-Attribute Utility Theory to Measure Social Preferences for Health States , 1982, Oper. Res..
[50] J. Heyse,et al. A regression-based method for estimating mean treatment cost in the presence of right-censoring. , 2000, Biostatistics.
[51] Peter C Austin,et al. A comparison of methods for analyzing health-related quality-of-life measures. , 2002, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[52] D. Hosmer,et al. Applied Logistic Regression , 1991 .
[53] D. Meltzer,et al. Accounting for Future Costs in Medical Cost-Effectiveness Analysis , 1997, Journal of health economics.
[54] J. Clouse,et al. Implications of controlling for comorbid conditions in cost-of-illness estimates: a case study of osteoarthritis from a managed care system perspective. , 2001, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[55] B. O'brien,et al. Economic evaluation of pharmaceuticals. Frankenstein's monster or vampire of trials? , 1996, Medical care.
[56] S M Gray,et al. Estimating a treatment effect from multidimensional longitudinal data. , 1998, Biometrics.
[57] L Goldman,et al. Stability of Time-tradeoff Utilities in Survivors of Myocardial Infarction , 1993, Medical decision making : an international journal of the Society for Medical Decision Making.
[58] M J Al,et al. Sample size calculation in economic evaluations. , 1998, Health economics.
[59] John C. Hershey,et al. Carrier Screening for Cystic Fibrosis , 1998, Medical decision making : an international journal of the Society for Medical Decision Making.
[60] M. Sculpher,et al. Representing uncertainty: the role of cost-effectiveness acceptability curves. , 2001, Health economics.
[61] Bartlett Ms. The use of transformations. , 1947 .
[62] M Johannesson,et al. A Note on Confidence Intervals in Cost-Effectiveness Analysis , 1998, International Journal of Technology Assessment in Health Care.
[63] U. Gerdtham,et al. Conversion factor instability in international comparisons of health care expenditure. , 1991, Journal of health economics.
[64] E. Feuer,et al. Estimating medical costs from incomplete follow-up data. , 1997, Biometrics.
[65] N. Freemantle,et al. Use of health‐related quality of life in prescribing research. Part 2: methodological considerations for the assessment of health‐related quality of life in clinical trials , 2004, Journal of clinical pharmacy and therapeutics.
[66] W. Busse,et al. Country-specific cost-effectiveness of early intervention with budesonide in mild asthma , 2004, European Respiratory Journal.
[67] A A Stinnett,et al. Net Health Benefits , 1998, Medical decision making : an international journal of the Society for Medical Decision Making.
[68] John Mullahy,et al. Net Health Benefits: A New Framework for the Analysis of Uncertainty in Cost-Effectiveness Analysis , 1998 .
[69] M J Al,et al. Costs, effects and C/E-ratios alongside a clinical trial. , 1994, Health economics.
[70] D G Altman,et al. Statistics Notes: The use of transformation when comparing two means , 1996, BMJ.
[71] J M Bland,et al. Transforming data. , 1996, BMJ.
[72] A. Mcguire,et al. Centre-specific or average unit costs in multi-centre studies? Some theory and simulation. , 2000, Health economics.
[73] Anastasios A Tsiatis,et al. Median Regression with Censored Cost Data , 2002, Biometrics.
[74] M A Koopmanschap,et al. Analysis of costs and cost-effectiveness in multinational trials. , 2001, Health policy.
[75] A. Ludbrook,et al. Comparing costing results in across country economic evaluations: the use of technology specific purchasing power parities. , 2005, Health economics.
[76] Daniel Polsky,et al. Design and analysis of unit cost estimation studies: How many hospital diagnoses? How many countries? , 2003, Health economics.
[77] S. Ramsey,et al. Design issues for conducting cost-effectiveness analyses alongside clinical trials. , 2001, Annual review of public health.
[78] P. Dolan,et al. Modeling valuations for EuroQol health states. , 1997, Medical care.
[79] P. O'Byrne,et al. Design and analytic considerations in determining the cost-effectiveness of early intervention in asthma from a multinational clinical trial. , 2001, Controlled Clinical Trials.
[80] B. O'brien,et al. A tale of two (or more) cities: geographic transferability of pharmacoeconomic data. , 1997, The American journal of managed care.
[81] Orton,et al. Multiple Imputation in Practice , 2001 .
[82] S. Thompson,et al. How should cost data in pragmatic randomised trials be analysed? , 2000, BMJ : British Medical Journal.
[83] 鳥居 泰彦,et al. 世界経済・社会統計 = World development indicators , 1998 .
[84] R D Etzioni,et al. On the use of survival analysis techniques to estimate medical care costs. , 1999, Journal of health economics.
[85] A. Mcguire,et al. Estimating medical care costs under conditions of censoring. , 2004, Journal of health economics.
[86] K. Schulman,et al. The economic evaluation of the FIRST study: design of a prospective analysis alongside a multinational phase III clinical trial. Flolan International Randomized Survival Trial. , 1996, Controlled clinical trials.
[87] D. Feeny,et al. Multiattribute utility function for a comprehensive health status classification system. Health Utilities Index Mark 2. , 1996, Medical care.
[88] K. Schulman,et al. Results of the Economic Evaluation of the FIRST Study: A Multinational Prospective Economic Evaluation , 1996, International Journal of Technology Assessment in Health Care.
[89] G. Torrance. Multi-attribute preference functions for a comprehensive health status classification system , 1992 .
[90] Milton C. Weinstein,et al. Recommendations for Reporting Cost-effectiveness Analyses , 1996 .
[91] M. Weinstein,et al. Theoretical Foundations of Cost-Effectiveness Analysis , 1996 .
[92] Andrew Briggs,et al. Missing... presumed at random: cost-analysis of incomplete data. , 2003, Health economics.
[93] Milton C Weinstein,et al. Principles of good practice for decision analytic modeling in health-care evaluation: report of the ISPOR Task Force on Good Research Practices--Modeling Studies. , 2003, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[94] S G Thompson,et al. Analysis and interpretation of cost data in randomised controlled trials: review of published studies , 1998, BMJ.
[95] Nicole A. Lazar,et al. Statistical Analysis With Missing Data , 2003, Technometrics.
[96] M H Liang,et al. Stability and responsiveness of utility measures. , 1994, Medical care.
[97] Grazyna Adamiak,et al. Methods for the economic evaluation of health care programmes, 3rd ed , 2006 .
[98] M. Gardner,et al. Confidence intervals rather than P values: estimation rather than hypothesis testing. , 1986, British medical journal.
[99] M. Gold,et al. Panel on cost-effectiveness in health and medicine. , 1996, Medical care.
[100] D Y Lin,et al. Incremental net benefit in randomized clinical trials , 2001, Statistics in medicine.